Phillies

Phillies president Andy MacPhail talks pitching injuries, how they will impact future dealings

Phillies president Andy MacPhail talks pitching injuries, how they will impact future dealings

NEW YORK -- It wasn't difficult to understand the Phillies' strategy in trading for veteran pitchers Jeremy Hellickson, Charlie Morton and Clay Buchholz over the last two seasons.

The Phillies gave up little in the form of talent to get the three pitchers. All they had to do was be willing to take on sizable one-year contracts because the three pitchers were salary dumps for their previous clubs. For their money, the Phillies added some veteran fortification to a young starting staff while rolling the dice that said veteran might perform well enough to bring back some value on the July trade market.

The strategy was sound.

But it has not worked.

"We're batting .333," club president Andy MacPhail said on Tuesday night.

Buchholz exited his second start with the club last week with a flexor-pronator injury near his right elbow and on Tuesday had surgery that with a recovery time of four to six months will end his season (see story).

Morton made four starts last season before blowing out his hamstring so severely that it ripped off the bone.

Hellickson pitched well for the club last season and continues to this season, but the Phillies' hope of getting value for him during last July's trade season never materialized, nor did the club's hope of turning him into a first-round draft pick this June. That scenario was scuttled when the pitcher accepted the team's qualifying offer of $17.2 million for this season.

For the $22.5 million that the Phillies sunk into Morton and Buchholz, they got six starts, 24 2/3 innings and a 6.56 ERA.

"I don't think anybody likes it," MacPhail said of the lack of return that the team got on Morton and Buchholz. "How could you like it? Nobody likes to see a $14 million investment go before you get [to the third start]."

Buchholz, 32, pitched just 7 1/3 innings in two starts and was tagged for 16 hits and 10 runs. He also pitched poorly in spring training but did not complain of an injury until he exited last Tuesday night's start.

MacPhail said Buchholz's fastball velocity in spring training was down "two or three miles per hour" from where the pitcher was at the end of last season with Boston.

Buchholz's drop in velocity and subsequent injury raises questions of whether he was healthy when the Phillies acquired him. The Red Sox apparently believed he was. They picked up his $13.5 million option for 2017 on Nov. 3, weeks before sending him to Philadelphia for minor-league infielder Josh Tobias on Dec. 20, and the Phillies performed customary pre-trade medical vetting.

Buchholz did miss the second half of the 2015 season with an elbow strain, but he finished 2016 by going 4-0 with a 2.63 ERA in seven starts from Aug. 18 until the end of the season.

The injuries to Buchholz and Morton, who also was 32 when the Phillies acquired him, illustrate the risks that teams take when they decide to acquire pitchers in their 30s.

"When these things happen, as an organization, we review everything that had us reach those decisions," MacPhail said. "It's just the nature of what you're dealing with. It goes to underscore the importance of having numbers [depth] and developing pitchers in your system.

"In Morton's case, he was injured trying to leg out a bunt. What you can do differently is not have to depend upon getting pitching from that area, really. I think there's a difference between reviewing your decision-making process and determining if there were any pieces of information that you should have considered that you didn't. I don't think that's the case. It's the nature of what you're dealing with. It's one of the reasons that you haven't seen us go beyond a year (in a contract). An organization can absorb an injury for a year. You just don't want one that's going to sink you."

MacPhail arrived in Philadelphia in the summer of 2015 and from the beginning made it clear that developing pitching would be an organizational priority. One of his mantras, dating to earlier stops in Baltimore and Chicago, is: "Grow the pitchers, buy the bats." Based on this ideology, it's difficult to envision the Phillies being big players in coming free-agent pitching markets. On the other hand, they could go big for a bat or two.

"I'm very confident that we're going to have the resources and the kind of ballpark where position players are going to be a lot easier to come by than pitching," MacPhail said. "Pitching is hard. I don't think that belief needed reinforcement. I have articulated that point. It's not a surprise, unfortunately.

"I think you have to stay open to any opportunity if it makes sense. But I have made it no secret, personally, that free-agent pitching is fragile and expensive by the time it gets to you. That said, I don't think you ever should rule anything out. We'll make decisions based on the information we have at the time."

Morphine found in Roy Halladay's system before fatal plane crash

Morphine found in Roy Halladay's system before fatal plane crash

Roy Halladay had morphine in his system when the plane he was piloting crashed and he tragically died in November, according to Halladay's autopsy report, released Friday.

Zolpidem, the generic name for Ambien, and amphetamines were also found in Halladay's system.

As TMZ points out via the Food and Drug Administration, the amount of Zolpidem found in Halladay's system (72 ng/ml) is more than enough to impair a driver and increase the risk of an accident.

Halladay had a blood alcohol content of 0.01, according to the autopsy report. 

The official cause of Halladay's death was blunt force trauma, with drowning a contributing factor.

The crash took place on Nov. 7 in the Gulf of Mexico, with more details emerging in a preliminary report from the National Transportation Safety Board two weeks later.

Nick Williams talks up Phillies to a free-agent Cy Young winner

uspresswire-ap-phillies-cubs-williams-arrieta.jpg
AP Images/USA Today Images

Nick Williams talks up Phillies to a free-agent Cy Young winner

It's not clear whether the Phillies will add a starting pitcher before opening day, but surely they would like to.

General manager Matt Klentak “is busting his ass every single day looking for every possible opportunity to upgrade our team from every perspective,” manager Gabe Kapler said on Tuesday. “That includes looking at every option possible for the rotation.”

Klentak has kept a close eye on the trade market, but has found the prices (i.e., the young talent that must be surrendered) for top, controllable starters to be prohibitive.

He has kept a close eye on the free-agent market, but the length of contracts that top pitchers are looking for has given him pause.

For months, the Phillies have distanced themselves from speculation that has connected them to elite level free-agent pitchers Yu Darvish and Jake Arrieta.

But with spring training less than a month away and both pitchers still unsigned, the Phillies would at least have to consider both pitchers if their asking prices experience a January thaw.

Six or seven years? No way.

Three years? Hmmm. Let's talk.

The Phillies are hosting a number of their young players this week. Rhys Hoskins, Jerad Eickhoff, Mark Leiter and Nick Williams were all in town on Tuesday.

Williams has set his sights on making the National League All-Star team in 2018.

“That's what I'm shooting for,” he said at Citizens Bank Park on Tuesday. “I think I had a pretty good year last year. I'm shooting for more now. I don't think being an All-Star is shooting too high.”

Williams, 24, hit .288 with 12 homers, 55 RBIs and an .811 OPS in 83 games, mostly in right field, with the big club as a rookie last season.

To give himself the best chance of surpassing those numbers — and achieving his goal of making the All-Star team — Williams has spent the offseason in Austin, Texas, working with personal trainer Jeremy Hills, a former University of Texas football player.

Williams is working hard on agility, which will help him in the outfield and on the base paths.

And guess who one of his daily workout partners is?

Free-agent pitcher Jake Arrieta.

Back in Austin, between reps and protein shakes, Williams has occasionally talked up Philadelphia as a potential landing spot to Arrieta, the 2015 NL Cy Young Award winner who will turn 32 in March.

“He loves it here,” Williams said of Arrieta, who, as a free agent and a Scott Boras client, is astute enough not to rule out any team, particularly one as deep-pocketed as the Phillies. “He has told me he likes working with young guys. I'm like, ‘All right, come on up.’ But I'm not writing the check. I don’t know what he wants. I don’t really dig into that because I'm not really in his position.”

Williams smiled.

“I hope to be one day,” he said.

Williams marveled at Arrieta's work ethic in the gym.

And he expressed gratitude for the kindness and generosity Arrieta has showed him.

“He's bought a lot of my protein shakes,” Williams said.

Time will tell if the Phillies add a starting pitcher to the group that already consists of Aaron Nola, Jerad Eickhoff, Vince Velasquez, Nick Pivetta, Zach Eflin and other youngsters. The hunch is they will, though it's unclear what the magnitude of that talent will be. Klentak's search for an arm likely won't stop with the addition of one pitcher and it will likely continue through July. And beyond. The quest to build a championship-caliber staff never stops.

“The pursuit is very real,” Kapler said of Klentak's search for pitching. “I have a lot of trust that we'll either go in [to spring training] with a new toy or we will pass on the opportunity because we're better off giving this collection of pitchers a really healthy look because we thought that we could go acquire that piece a little bit later on this season or in the offseason next year.”